货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
P710-1.0mg |
Mouse Anti-Mouse PD-1 (CD279) (Clone 384-35) - Recombinant in vivo Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0mg |
2800 |
More |
P710-100mg |
Mouse Anti-Mouse PD-1 (CD279) (Clone 384-35) - Recombinant in vivo Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
100800 |
More |
P710-25mg |
Mouse Anti-Mouse PD-1 (CD279) (Clone 384-35) - Recombinant in vivo Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
49000 |
More |
P710-5.0mg |
Mouse Anti-Mouse PD-1 (CD279) (Clone 384-35) - Recombinant in vivo Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5.0mg |
11200 |
More |
P710-50mg |
Mouse Anti-Mouse PD-1 (CD279) (Clone 384-35) - Recombinant in vivo Functional Grade Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
77000 |
More |
P720-1.0mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) - 1.0 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0 mg |
2001 |
More |
P720-100mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
P720-25mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
P720-50mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
P720-5mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
P725-500μg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Evolocumab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500 μg |
5451 |
More |
P800-1.0mg |
Anti-Human PD-1 (Tislelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1mg |
2001 |
More |
P800-100mg |
Anti-Human PD-1 (Tislelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
68310 |
More |
P800-25mg |
Anti-Human PD-1 (Tislelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27255 |
More |
P800-5.0mg |
Anti-Human PD-1 (Tislelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5mg |
7590 |
More |
P800-50mg |
Anti-Human PD-1 (Tislelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
47610 |
More |
P801-100mg |
Anti-Human PD-1 (Toripalimab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
P801-1mg |
Anti-Human PD-1 (Toripalimab) - 1.0 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0 mg |
2001 |
More |
P801-25mg |
Anti-Human PD-1 (Toripalimab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
P801-50mg |
Anti-Human PD-1 (Toripalimab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
P801-5mg |
Anti-Human PD-1 (Toripalimab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
P802-500μg |
Anti-Human PD-1 (Toripalimab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500 μg |
5451 |
More |
P805-500μg |
Anti-Human PD-1 (Tislelizumab) – Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5451 |
More |
P810-1.0mg |
Anti-Human PD-1 (Camrelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1mg |
2001 |
More |
P810-100mg |
Anti-Human PD-1 (Camrelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100mg |
68310 |
More |
P810-25mg |
Anti-Human PD-1 (Camrelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25mg |
27255 |
More |
P810-5.0mg |
Anti-Human PD-1 (Camrelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5mg |
7590 |
More |
P810-50mg |
Anti-Human PD-1 (Camrelizumab) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50mg |
48300 |
More |
P815-500μg |
Anti-Human PD-1 (Camrelizumab) – Fc Muted? Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500μg |
5451 |
More |
P820-1.0mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) - 1.0 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
1.0 mg |
2001 |
More |
P820-100mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) - 100 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
100 mg |
68310 |
More |
P820-25mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) - 25 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25 mg |
27255 |
More |
P820-50mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) - 50 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50 mg |
48300 |
More |
P820-5mg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) - 5 mg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
5 mg |
7590 |
More |
P825-500μg |
Anti-Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) (Alirocumab) – Fc Muted? - 500 μg Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
500 μg |
5451 |
More |
R1000-0.1 mg |
Anti-Human RICK (NT) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
R1000-20ug |
Anti-Human RICK (NT) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
R1001-0.1 mg |
Anti-Mouse Receptor Interacting Protein 3 (RIP3) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
R1001-20 μg |
Anti-Mouse Receptor Interacting Protein 3 (RIP3) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
R1002-0.1 mg |
Anti-Human RAIDD (CT) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
R-100-200μg |
Anti-Rhesus IgG Kappa (Clone 2G11.7.3) - Purified Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
200μg |
2277 |
More |
R1002-20ug |
Anti-Human RAIDD (CT) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
R100-25 μg |
Recombinant Human Relaxin-3 Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
25μg |
6992 |
More |
R1003-0.1 mg |
Anti-Human RAIDD (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
0.1mg |
8602 |
More |
R1003-20 μg |
Anti-Human RAIDD (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
20μg |
1857 |
More |
R1004-50 μg |
RAIDD (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
R1005-50 μg |
RAIDD (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
R1006-50 μg |
RICK (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
R1007-50 μg |
RICK (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |
R1008-50 μg |
Receptor Interacting Protein 3 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
|
Leinco |
50μg |
2150 |
More |